Meeting of the Advisory Committee on Infant Mortality, 29588 [2021-11504]
Download as PDF
<![CDATA[
29588
Federal Register / Vol. 86, No. 104 / Wednesday, June 2, 2021 / Notices
HRSA specifically requests comments
on: (1) The necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–11542 Filed 6–1–21; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Committee on
Infant Mortality
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Committee on Infant Mortality (ACIM)
has scheduled a public meeting.
Information about ACIM and the agenda
for this meeting can be found on the
ACIM website at https://www.hrsa.gov/
advisory-committees/infant-mortality/
index.html.
DATES: June 22, 2021, 12:00 p.m.–4:00
p.m. Eastern Time (ET) and June 23,
2021, 12:00 p.m.–4:00 p.m. ET.
ADDRESSES: This meeting will be held
via webinar. The webinar link and login information will be available at
ACIM’s website before the meeting:
https://www.hrsa.gov/advisorycommittees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT:
Vanessa Lee, MPH, Acting Designated
Federal Official, Maternal and Child
Health Bureau, HRSA, 5600 Fishers
Lane, Rockville, Maryland 20857; 301–
443–0543; or SACIM@hrsa.gov.
SUPPLEMENTARY INFORMATION: The ACIM
is authorized by section 222 of the
Public Health Service Act (42 U.S.C.
217a), as amended. The Committee is
governed by provisions of Public Law
92–463, as amended, (5 U.S.C. App. 2),
which sets forth standards for the
formation and use of Advisory
Committees.
The ACIM advises the Secretary of
HHS on department activities and
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:49 Jun 01, 2021
Jkt 253001
programs directed at reducing infant
mortality and improving the health
status of pregnant women and infants.
The ACIM represents a public-private
partnership at the highest level to
provide guidance and focus attention on
the policies and resources required to
address the reduction of infant mortality
and the improvement of the health
status of pregnant women and infants.
With a focus on life course, the ACIM
addresses disparities in maternal health
to improve maternal health outcomes,
including preventing and reducing
maternal mortality and severe maternal
morbidity. The ACIM provides advice
on how best to coordinate myriad
federal, state, local, and private
programs and efforts that are designed
to deal with the health and social
problems impacting infant mortality and
maternal health, including
implementation of the Healthy Start
program and maternal and infant health
objectives from the National Health
Promotion and Disease Prevention
Objectives (i.e., Healthy People 2030).
The agenda for the June 22–23, 2021,
meeting is being finalized and may
include the following topics: Discussion
of recommendations by ACIM to the
Secretary; updates from HRSA’s
Maternal and Child Health Bureau, and
other federal agencies; the Centers for
Disease Control and Prevention’s
Pregnancy Risk Assessment Monitoring
System survey; and patient-physician
racial concordance in health care.
Agenda items are subject to change as
priorities dictate. Refer to the ACIM
website for any updated information
concerning the meeting.
Members of the public will have the
opportunity to provide written or oral
comments. Requests to submit a written
statement or make oral comments to the
ACIM should be sent to Vanessa Lee,
using the email address above at least 3
business days prior to the meeting.
Public participants may submit written
statements in advance of the scheduled
meeting by emailing SACIM@hrsa.gov.
Oral comments will be honored in the
order they are requested and may be
limited as time allows.
Individuals who plan to attend and
need special assistance or another
reasonable accommodation should
notify Vanessa Lee at the contact
information listed above at least 10
business days prior to the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–11504 Filed 6–1–21; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health.
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Music and Health.
Date: June 24, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: W. Ernest Lyons, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Rockville, MD 20852,
301–496–4056, lyonse@ninds.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Small Vessel VCID
Biomarkers Validation Consortium Sites &
Coordinating Center Review (U01 & U24).
Date: June 25, 2021.
Time: 10:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Mir Ahamed Hossain,
PhD, Scientific Review Officer, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Rockville, MD 20852,
301–496–9223, mirahamed.hossain@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
E:\FR\FM\02JNN1.SGM
02JNN1
]]>Agencies
[Federal Register Volume 86, Number 104 (Wednesday, June 2, 2021)]
[Notices]
[Page 29588]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11504]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Committee on Infant Mortality
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Committee on Infant Mortality (ACIM)
has scheduled a public meeting. Information about ACIM and the agenda
for this meeting can be found on the ACIM website at https://www.hrsa.gov/advisory-committees/infant-mortality/.
DATES: June 22, 2021, 12:00 p.m.-4:00 p.m. Eastern Time (ET) and June
23, 2021, 12:00 p.m.-4:00 p.m. ET.
ADDRESSES: This meeting will be held via webinar. The webinar link and
log-in information will be available at ACIM's website before the
meeting: https://www.hrsa.gov/advisory-committees/infant-mortality/.
FOR FURTHER INFORMATION CONTACT: Vanessa Lee, MPH, Acting Designated
Federal Official, Maternal and Child Health Bureau, HRSA, 5600 Fishers
Lane, Rockville, Maryland 20857; 301-443-0543; or [email protected].
SUPPLEMENTARY INFORMATION: The ACIM is authorized by section 222 of the
Public Health Service Act (42 U.S.C. 217a), as amended. The Committee
is governed by provisions of Public Law 92-463, as amended, (5 U.S.C.
App. 2), which sets forth standards for the formation and use of
Advisory Committees.
The ACIM advises the Secretary of HHS on department activities and
programs directed at reducing infant mortality and improving the health
status of pregnant women and infants. The ACIM represents a public-
private partnership at the highest level to provide guidance and focus
attention on the policies and resources required to address the
reduction of infant mortality and the improvement of the health status
of pregnant women and infants. With a focus on life course, the ACIM
addresses disparities in maternal health to improve maternal health
outcomes, including preventing and reducing maternal mortality and
severe maternal morbidity. The ACIM provides advice on how best to
coordinate myriad federal, state, local, and private programs and
efforts that are designed to deal with the health and social problems
impacting infant mortality and maternal health, including
implementation of the Healthy Start program and maternal and infant
health objectives from the National Health Promotion and Disease
Prevention Objectives (i.e., Healthy People 2030).
The agenda for the June 22-23, 2021, meeting is being finalized and
may include the following topics: Discussion of recommendations by ACIM
to the Secretary; updates from HRSA's Maternal and Child Health Bureau,
and other federal agencies; the Centers for Disease Control and
Prevention's Pregnancy Risk Assessment Monitoring System survey; and
patient-physician racial concordance in health care. Agenda items are
subject to change as priorities dictate. Refer to the ACIM website for
any updated information concerning the meeting.
Members of the public will have the opportunity to provide written
or oral comments. Requests to submit a written statement or make oral
comments to the ACIM should be sent to Vanessa Lee, using the email
address above at least 3 business days prior to the meeting. Public
participants may submit written statements in advance of the scheduled
meeting by emailing [email protected]. Oral comments will be honored in
the order they are requested and may be limited as time allows.
Individuals who plan to attend and need special assistance or
another reasonable accommodation should notify Vanessa Lee at the
contact information listed above at least 10 business days prior to the
meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-11504 Filed 6-1-21; 8:45 am]
BILLING CODE 4165-15-P
